Genome-Based Therapeutics: Targeted Drug Discovery and Development
Publisher: National Academies Press 2012
Number of pages: 89
Objectives: To examine the impact of and investment in genetic and genomic technologies and data in drug discovery and development; To examine and discuss the challenges for incorporating genomic technologies into drug development and to explore solutions to remedy those challenges; To discuss and explore how innovative, novel, and global partnerships between academia, industry, foundations, and government can enable the use of genomic information for more efficient and effective drug discovery and development programs.
Home page url
Download or read it online for free here:
by Tarek A Leil, Sergey Ermakov (eds) - Frontiers Media S.A.
Quantitative Systems Pharmacology is still in its infancy, but has tremendous potential to change the way we approach biomedical research. QSP is really the integration of two disciplines: 'Systems Biology' and 'Quantitative Pharmacology'.
by J. Eric McDuffie (ed.) - InTech
Because the incidence of neurobehavioral hazards and risks of exogenous compounds remain subject matter of interest, predictive tools have evolved, including novel translational in vitro models, biomarkers, newer epidemiological research tools, etc.
by G. M. Woerlee - Booklocker.com, Inc.
The author of this book teaches the basic elements of pharmacokinetics of anesthetic drugs in the form of conversations between a curmudgeonly older anesthesiologist and an anesthesia resident as they administer anesthesia.
- U.S. Department of Health and Human Services
The publication, Approved Drug Products (commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act.